Author:
Blasco H.,Veyrat-Durebex C.,Bocca C.,Patin F.,Vourc’h P.,Kouassi Nzoughet J.,Lenaers G.,Andres C. R.,Simard G.,Corcia P.,Reynier P.
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Mitsumoto, H., Brooks, B. R. & Silani, V. Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved? Lancet Neurol 13, 1127–1138, doi:S1474-4422(14)70129-2 (2014).
2. Dupuis, L. et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 70, 1004–1009 (2008).
3. Fergani, A. et al. Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. J Lipid Res 48, 1571–1580 (2007).
4. Fonteh, A. N. & Fisher, R. D. Combining lipidomics and proteomics of human cerebrospinal fluids. Methods Mol Biol 579, 71–86, https://doi.org/10.1007/978-1-60761-322-0_4 (2009).
5. Lauwers, E., Goodchild, R. & Verstreken, P. Membrane Lipids in Presynaptic Function and Disease. Neuron 90, 11–25, https://doi.org/10.1016/j.neuron.2016.02.033 (2016).
Cited by
112 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献